Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul 15;7(7):1808-12.
eCollection 2014.

Clinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues

Affiliations

Clinical significance of methylation of E-cadherin and p14ARF gene promoters in skin squamous cell carcinoma tissues

Jian Wu et al. Int J Clin Exp Med. .

Abstract

Epigenetic regulation of genes by DNA methylation contributes to cancer. The present study sought to identify methylation changes in the promoters of E-cadherin and p14ARF, two genes with potential cancer roles promoting in skin squamous cell carcinoma. Skin squamous cell carcinoma specimens were collected from 40 patients and normal skin tissues were collected from 30 individuals as controls. Promoter methylation was detected for E-cadherin and p14ARF by methylation-specific PCR. Correlations between E-cadherin or p14ARF methylation and clinicopathological parameters were analyzed by the Spearman rank test. Methylation of E-cadherin (37.5%) and p14ARF (60.0%) was significantly more common in skin squamous cell carcinoma than in normal skin tissue (10.0 and 6.7%, respectively; P < 0.05). Additionally, E-cadherin and p14ARF methylation were positively correlated within skin squamous cell carcinoma (r = 0.422, P = 0.007). Furthermore, methylation of these gene promoters in skin squamous cell carcinoma was correlated with differentiation, lymph node metastasis, and clinical stage (P < 0.05). Aberrant methylation in promoters of E-cadherin and p14ARF may promote occurrence and progression of skin squamous cell carcinoma.

Keywords: DNA methylation; E-cadherin; Skin squamous cell carcinoma; clinicopathological parameter; p14ARF.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Electrophoretogram of E-cadherin and p14ARF methylation in skin squamous cell carcinoma and normal skin tissue. PCR amplification products were separated on 2% agarose gel. If only unmethylated bands were observed during electrophoresis of MSP products, the sample was recorded as unmethylated; if methylated bands were observed, the sample was recorded as methylated. Note: Ca = skin squamous cell carcinoma (Stage II); N = normal skin; M = methylated; U = unmethylated.

References

    1. Luczak MW, Jagodzinski PP. The role of DNA methylation in cancer development. Folia Histochem Cytobiol. 2006;44:143–154. - PubMed
    1. Moskalev EA, Eprintsev AT, Hoheisel JD. DNA methylation profiling in cancer: from single nucleotides towards methylome. Mol Biol (Mosk) 2007;41:793–807. - PubMed
    1. Wu HC, Wang Q, Yang HI, Tsai WY, Chen CJ, Santella RM. Global DNA methylation levels in white blood cells as a biomarker for hepatocellular carcinoma risk: a nested case-control study. Carcinogenesis. 2012;33:1340–1345. - PMC - PubMed
    1. Chan KC, Lai PB, Mok TS, Chan HL, Ding C, Yeung SW, Lo YM. Quantitative analysis of circulating methylated DNA as a biomarker for hepatocellular carcinoma. Clin Chem. 2008;54:1528–1536. - PubMed
    1. Yu J, Zhu T, Wang Z, Zhang H, Qian Z, Xu H, Gao B, Wang W, Gu L, Meng J, Wang J, Feng X, Li Y, Yao X, Zhu J. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res. 2007;13:7296–7304. - PubMed

LinkOut - more resources